← Leaderboards
Marc R. Blackman
Johns Hopkins University
$130,338
Attributed
$130,338
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$130,338 · 4
By mechanism
M01$130,338 · 4
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Pauline M Maki$14,436,003
- Samuel Durso$1,084,854
- Christopher J Hoffmann$8,953,843
- Paul Talalay$3,109,089
- Zahoor Ahmad Shah$2,990,250
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchInsulinlike Growth FactorHuman Therapy EvaluationHormone TherapyHormone Regulation /Control MechanismSomatotropinCardiovascular FunctionHuman Old Age (65+)AgingSex HormonesRespiratory FunctionPlacebosMuscle MetabolismAdipose TissueBody CompositionTestosteroneMuscle StrengthSarcopeniaEstrogensFemaleQuality Of LifeMuscle FunctionBone Metabolism
Grant awards (29)
Effects of Chronic Pain, Morphine, and Placebo on Neuroendocrine Function in Men$1,318,000
Z01 · FY2007 · AT · contact PI
The Effects Of CAM Biological Agents In Human Prostate Cells In Vitro$400,000
Z01 · FY2007 · AT · contact PI
MAOA/H202 regulation by Dexamethasone & other Steroids in muscle and brain cells$179,000
Z01 · FY2007 · AT · contact PI
Suppression of the GH/IGF-I Axis In Women With Rheumatoi$0
Z01 · FY2006 · AT · contact PI
Effects of Chronic Pain, Morphine, and Placebo on Neuroe$0
Z01 · FY2006 · AT · contact PI
MAOA/H202 regulation by Dexamethasone & other Steroids i$0
Z01 · FY2006 · AT · contact PI
Effects of Chronic Pain, Morphine, and Placebo$0
Z01 · FY2005 · AT
MAOA/H202 regulation by Dexamethasone &other Steroids$0
Z01 · FY2005 · AT
Suppression of the GH/IGF-I Axis In Women With RA$0
Z01 · FY2005 · AT
Carnitine and Dexamethasone: Isolated Human Myocytes$0
Z01 · FY2004 · AT
GH/IGF-I Axis Suppression/Rheumatoid Arthritis In Women$0
Z01 · FY2004 · AT
Male Neuroendocrinology: Chronic Pain/Morphine/Placebo$0
Z01 · FY2004 · AT
Suppression of the GH/IGF-I Axis In Women With Rheumatoi$0
Z01 · FY2003 · AT
Effects Carnitine in Isolated Adipocytes &Myocytes$0
Z01 · FY2003 · AT
Suppression of GH/IGF-I Axis In Women With RA$0
Z01 · FY2002 · AT
GROWTH HORMONE AND SEX STEROID EFFECTS ON SKELETAL MUSCLE IN OLDER WOMEND &MEN$0
M01 · FY2002 · RR
SCREENING FOR GROWTH HORMONE AND SEX STEROID EFFECTS$0
M01 · FY2002 · RR
PHARMACOKINETIC &SAFETY EVALUATION OF RECOMBINANT HUMAN PROLACTIN$0
M01 · FY2002 · RR
Cam Biological Agent Effects In Cancer Cells In Vitro$0
Z01 · FY2002 · AT
SCREENING FOR GROWTH HORMONE AND SEX STEROID EFFECTS$0
M01 · FY2001 · RR
GROWTH HORMONE AND SEX STEROID EFFECTS ON SKELETAL MUSCLE IN OLDER WOMEND &MEN$0
M01 · FY2001 · RR
PHARMACOKINETIC &SAFETY EVALUATION OF RECOMBINANT HUMAN PROLACTIN$0
M01 · FY2001 · RR
PHARMACOKINETIC &SAFETY EVALUATION OF RECOMBINANT HUMAN PROLACTIN$65,169
M01 · FY2000 · RR
SCREENING FOR GROWTH HORMONE AND SEX STEROID EFFECTS$65,169
M01 · FY2000 · RR
GROWTH HORMONE AND SEX STEROID ON MUSCLE IN ELDERS$0
M01 · FY2000 · RR
EXERCISE TRAINING IN OLDER HYPERTENSIVE MEN AND WOMEN$0
M01 · FY2000 · RR
EXERCISE TRAINING IN OLDER HYPERTENSIVE MEN AND WOMEN$0
M01 · FY2000 · RR
GROWTH HORMONE AND SEX STEROID ON MUSCLE IN ELDERS$0
M01 · FY2000 · RR
GROWTH HORMONE AND SEX STEROID ON MUSCLE IN ELDERS$0
M01 · FY2000 · RR